William Blum

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri et al. · Cancer Discovery · 2016 · 1K citations · Full text

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

Ramiro Garzon, Shujun Liu, Muller Fabbri et al. · Blood · 2009 · 768 citations · Full text

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2017 · 651 citations · Full text

Hematological Malignancy, Version 3.2017, Oncology +14

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

Alan G. Ramsay, Amy J. Johnson, Abigail M. Lee et al. · Journal of Clinical Investigation · 2008 · 587 citations · Full text

Autoimmune Disease, Allergy, T-regulatory Cell +12

Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine

William Blum, Ramiro Garzon, Rebecca B. Klisovic et al. · Proceedings of the National Academy of Sciences · 2010 · 453 citations · Full text